Posts Tagged biologicals

ASC Coding and Billing: Know What’s Important

By Brenda Chidester-Palmer, CPC, CPC-I, CEMC, CASCC

The basics of ambulatory surgery center (ASC) coding and billing aren’t hard to master, but they do differ from physician and facility requirements. The following overview will help you know what’s most important in the ASC setting.

Definition of ASC

To understand correct coding and billing for an ASC, you must first understand what an ASC is.

The Medicare Carriers Manual, section 10.1, defines an ASC as a distinct entity, operating exclusively to furnish outpatient surgical services. ASCs are not in the business of providing office visits, laboratory services, diagnostic tests, etc.

A hospital-operated facility may be considered by Medicare to be either an ASC or a provider-based department of the hospital, as defined in 42 CFR 413.65. To provide and bill services performed in an ASC, the ASC must enter into a participating provider agreement with the Centers for Medicare & Medicaid Services (CMS).

Basic Coding and Billing

ASCs use a combination of hospital and physician billing. Although ASCs use CPT® and HCPCS Level II codes to bill most of their services (as do physicians), some payers will allow an ASC to bill ICD-9-CM procedure codes (like a hospital). Some payers even base implant reimbursement on revenue code classification.

It’s important to use the proper form when submitting claims. Medicare pays for ASC services under Part B and requires the CMS-1500 claim form. Some third-party carriers will accept the CMS-1500 form, while others allow the UB04.

Approved List of Surgical Procedures

For Medicare patients, you cannot perform just any procedure in the ASC setting. Medicare has an “approved” list of procedures for the ASC that CMS has determined not to pose a significant safety risk, and that are not expected to require an overnight stay following the surgical procedure. The list of approved procedures is based on the criteria:

  • They are NOT emergent or life threatening (for example, a heart transplant or reattachment of a severed limb).
  • They CANNOT be performed safely in a physician’s office.
  • They can be elective.
  • They can be urgent.

Procedures also do not involve major blood vessels or result in major blood loss, and cannot involve prolonged invasion of a body cavity.

Medicare publishes this list of covered procedures annually. Updates are published quarterly, or as necessary. The file consists of two addenda listing approved surgical procedures and covered ancillary services.

Addendum AA (Final ASC-covered Surgical Procedures) includes comments, payment indicators, and final payment amounts for covered surgical procedures. (See the Addendum AA example on the next page.)

Addendum BB (Final Integral to Covered Surgical Procedures) covers included and separately billable ancillary services. (See the Addendum BB example on the next page.)

Other addenda included in the file tell us how to interpret the comments and indicators listed on addenda AA and BB. You should have this file and refer to it frequently when billing CMS for ASC services. These addenda are:

  • Addendum DD1 – Final ASC Payment Indicators
  • Addendum DD2 – Final ASC Comment Indicators
  • Addendum EE – Surgical Procedures to Be Excluded from Payment
  • Addendum EE is the “Excluded from Payment” list. If these procedures are performed in the ASC, you may not be paid unless there were extenuating circumstances.

(See examples of Addendum DD1, Addendum DD2, and Addendum EE on the following pages.)

Packaged Services and Separate Payment

Payments to ASCs are “packaged,” which means related services are bundled together and paid in one lump sum.

Examples of packaged items include:


Some categories listed above include a note stating “not on pass-through status.” This means that even though payment is based on a package price, some items are “carved out,” or may be reported and paid in addition to the package price for the surgical procedure. Be aware of the supplies that have pass-through status: You do not want to miss an opportunity to capture the correct reimbursement.

Other items that may be reported separately include brachytherapy sources, as well as certain items and services that CMS has designated as contractor priced (e.g., procurement of corneal tissue).

Medicare Claims Submissions

There is a separate set of billing rules for ASCs. While some issues may be addressed by CMS, most billing guidelines are best obtained from your local carrier or intermediary. Some carriers/intermediaries issue very detailed guides (e.g., Trailblazer), while others may simply provide a list of links to the CMS website (e.g., Empire).

To reiterate, an ASC must not report separate line items, HCPCS Level II codes, or any other charges for procedures, services, drugs, devices, or supplies that are packaged into the payment allowance for covered surgical procedures. The allowance for the surgical procedure itself includes these other services or items.

CMS does, however, strongly encourage billing for drug and biologicals that are eligible for separate payment. ASCs should report supplies with the correct HCPCS Level II code and correct number of units on the claim form.

Device Intensive Procedures

A modified (and somewhat confusing) payment methodology is used for device-intensive procedures (i.e., procedures done specifically to insert a device, such as a pacemaker).

The ASC will get paid for the device, but does not submit a separate line item for the device. The ASC would instead include the cost of the device in the procedure code and submit one line item. ASCs are not allowed to base price on the allowable code from the Medicare Physician Fee Schedule (MPFS).

For example, if a device intensive procedure is performed, and the formula is to bill the Medicare allowable plus 10 percent, you may be leaving money on the table. If the 10 percent increase does not cover the cost for the device, the money will not be recouped. It is important to know the cost to the ASC and add the cost of the device into the allowable. See Tables 1 and 2 for the right and wrong ways to bill a device intensive procedure.

Modifiers in the ASC

Some modifiers used in the ASC are the same as those used by physicians, while others are unique to the ASC facility. Modifiers recognized for ASC claim filing are (these are abbreviated descriptions):

  • 52 Reduced services
  • 59 Distinct separate procedure
  • 73 Procedure discontinued after prep for surgery
  • 74 Procedure discontinued after anesthesia administered
  • RT Right side
  • LT Left side
  • TC Technical component
  • FB Device furnished at no cost/full credit
  • FC Device furnished at partial credit
  • PT Screening service converted to a diagnostic or therapeutic service
  • PA Wrong body part
  • PB Surgery wrong patient
  • PC Wrong surgery on patient
  • GW Surgery not related to hospice patient’s terminal condition

ASCs have their own modifiers for a discontinued procedure. Modifier 73 Discontinued outpatient hospital/ambulatory surgery center (ASC) procedure prior to the administration of anesthesia is used when preparation for surgery has begun, but anesthesia has not been administered. The patient is taken back to the “prep” area and has completed paperwork, etc. The reasons may be the patient has a low grade temperature, or has eaten within the past four hours. The facility charges for the preparation, etc., but adds the modifier to show the procedure was not completed.

Modifier 74 Discontinued outpatient hospital/ambulatory surgery centers (ASC) procedure after administration of anesthesia is used when the procedure is terminated after anesthesia is administered. Plans can pay from 25 percent to 65 percent of the allowable amount, based on the modifier and documentation of how much of the service was performed.

New modifier PT Colorectal cancer screening test; converted to diagnostic test or other procedure designates that a screening colonoscopy was converted to a diagnostic or therapeutic service. For example, a patient presents to the ASC for a screening colonoscopy. He is not high risk and has no symptoms or complaints. During the colonoscopy, a polyp is found in the sigmoid. The ASC reports 45380 Colonoscopy, flexible, proximal to splenic flexure; with biopsy, single or multiple instead of 45378 Colonoscopy, flexible, proximal to splenic flexure; diagnostic, with or without collection  of specimen(s) by brushing or washing, with or without colon decompression (separate procedure) or G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk. Modifier PT designates the procedure was planned as a screening, but resulted as a diagnostic procedure. For Medicare patients, this allows the procedure to be paid as a screening with no co-insurance.

Commercial Plans

Commercial plans may or may not follow CMS policy for ASC claim filing. Check the carrier’s site for information on claim filing, and check your contract with the payer.

Brenda Chidester-Palmer, CPC, CPC-I, CEMC, CASCC, is the principal of Palmer Coding Consultant, providing audits and education to physicians in northeast Texas. She has 25 years experience in both single- and multi-specialty practices. Brenda is the former coding compliance manager of Kelsey-Seybold Clinic, a 300 physician practice in Houston. She has spoken nationally at conferences and AAPC workshops, teaches PMCC curriculum, and is a former coding educator at San Jacinto Junior College in Pasadena, Texas. Brenda was an officer of the Houston, Texas chapter and former AAPC National Advisory Board (NAB) member.

October 1st, 2012

No Comments

April OPPS Additions, Changes, Deletions

The Centers for Medicare & Medicaid Services (CMS) has posted April 2012 changes to billing instructions for payment policies implemented in the hospital Outpatient Prospective Payment System (OPPS). The April 2012 updated Integrated Outpatient Code Editor (I/OCE) and OPPS Pricer will reflect the HCPCS Level II, ambulatory payment classification (APC), HCPCS modifier, and revenue code additions, changes, and deletions as identified in change request (CR) 7748. The April 2012 revisions to I/OCE data files, instructions, and specifications are provided in CR 7751, “April 2012 Integrated Outpatient Code Editor (I/OCE) Specifications Version 13.1.”

Noteworthy Changes

1. For services provided on or after Jan. 1, 2012, the descriptor for CPT® 33249 has been changed to read “Insertion or replacement of permanent pacing cardioverter-defibrillator system with transvenous lead(s), single or dual chamber.” Due to clinical inappropriateness, this has prompted the removal of HCPCS Level II code C1882 Cardioverter-defibrillator, other than single or dual chamber (implantable) from the list of device codes required to be billed with CPT® code 33249 on the procedure-to-device edit list. This change is retroactive to Jan. 1, 2012.

2. For new service (fluorescent vascular angiography), HCPCS Level II code C9733 Non-ophthalmic fluorescent vascular angiography (SI = Q2 and APC = 0397, vascular imaging) is assigned for $154.87 payment (minimum unadjusted copayment = $30.98) under the OPPS, effective April 1, 2012. HCPCS Level II code C9733, assigned to APC 0397, describes SPY® Fluorescence Vascular Angiography and other types of non-ophthalmic fluorescent vascular angiography.

3. Drugs and biologicals with OPPS pass-through status, effective April 1, 2012, are:

C9288 Injection, centruroides (scorpion) immune f(ab)2 (equine), 1 vial

C9289 Injection, asparaginase Erwinia chrysanthemi, 1,000 international units (I.U.)

C9290 Injection, bupivacaine liposome, 1 mg

C9291 Injection, aflibercept, 2 mg vial

4. Payment rates for certain HCPCS Level II codes effective July 1- Sept. 30, 2011 are:

HCPCS Code Status Indicator APC Short Descriptor Corrected Payment Rate Corrected Min. Unadjusted Copayment
J0735 K 0935 Clonidine hydrochloride $35.67 $7.13
J1212 K 1221 Dimethyl sulfoxide 50% 50 ML $84.55 $16.91
J1756 K 9046 Iron sucrose injection $0.34 $0.07
J9245 K 0840 Inj melphalan hydrochl 50 MG $1,308.97 $261.79

5. The following HCPCS Level II codes describe products that can be used as skin substitutes (They will be separately paid only when used with one of the CPT® codes describing the application of a skin substitute (15271-15278)):

HCPCS Level II Code APC Short Descriptor Status Indicator
C9358 9358 SurgiMend, fetal K
C9360 9360 SurgiMend, neonatal K
C9363 9363 Integra Meshed Bil Wound Mat K
C9366 9366 EpiFix wound cover G
C9367 9367 Endoform Dermal Template G
Q4100 N/A Skin substitute, NOS N
Q4101 1240 Apligraf K
Q4102 1241 Oasis wound matrix K
Q4103 1242 Oasis burn matrix K
Q4104 1243 Integra BMWD K
Q4105 1244 Integra DRT K
Q4106 1245 Dermagraft K
Q4107 1246 Graftjacket K
Q4108 1247 Integra matrix K
Q4110 1248 Primatrix K
Q4111 1252 Gammagraft K
Q4112 1249 Cymetra injectable K
Q4113 1250 Graftjacket xpress K
Q4114 1251 Integra flowable wound matri K
Q4115 1287 Alloskin K
Q4116 1270 Alloderm K
Q4118 1342 Matristem micromatrix K
Q4119 1351 Matristem wound matrix K
Q4121 1345 Theraskin K
Q4122 1419 Dermacell K
Q4124 9365 Oasis Ultra Tri-Layer Matrix G
Q4130 N/A Strattice TM N

For the complete CR, see CMS Transmittal 2418.

March 16th, 2012

1 Comment

CMS Clarifies Proper Discarded Drug Use

Recent guidance issued by the Centers for Medicare & Medicaid Services (CMS) clarifies the appropriate use of modifier JW Discarded drug not administered when reporting unused units of drugs and biologicals for reimbursement. Failure to follow this guidance could result in excessive units billing.

Medicare reimburses physicians, hospitals, and other providers or suppliers for the unused units of a single-use vial or other single-use package as well as the dose administered up to the amount indicated on the vial or package label.

Properly Use Modifier JW

Report the number of unused units of a drug or biological on a separate line and append modifier JW to the applicable HCPCS Level II code.

CMS provides this example of proper billing:

“a single use vial that is labeled to contain 100 units of a drug has 95 units administered to the patient and 5 units discarded. The 95 unit dose is billed on one line, while the discarded 5 units may be billed on another line by using the JW modifier. Both line items would be processed for payment.”

When Not to Use Modifier JW

Do not use modifier JW to report unused units if the amount used was less than the billing unit. When the billing unit is equal to or greater than the total actual dose and the amount discarded, modifier JW is not permitted.

CMS provides this example of improper billing:

“One billing unit for a drug is equal to 10mg of the drug in a single use vial. A 7 mg dose is administered to a patient while 3mg of the remaining drug is discarded. The 7mg dose is billed using one billing unit that represents 10mg on a single line item.  The single line item of 1 unit would be processed for payment of the total 10mg of drug administered and discarded. Billing another unit on a separate line item with the JW modifier for the discarded 3 mg of drug is not permitted because it would result in overpayment.”

Refer to CMS Transmittal 1962, Change Request (CR) 6711, issued April 30, for specific language.

May 14th, 2010

3 Comments

April 2010 OPPS Update Sets the Record Straight

The April 2010 hospital Outpatient Prospective Payment System (OPPS) update, released Feb. 26, adds several HCPCS Level II codes to reflect coverage changes, reiterates billing instructions on several points, and corrects payment rate errors in the January and October 2009 OPPS Pricer.

(more…)

March 12th, 2010

No Comments

TrailBlazer Revises Drugs & Biologicals LCDs

Health care providers in Colorado, New Mexico, Oklahoma and Texas submitting claims to TrailBlazer Health Enterprises should be aware of revisions the jurisdiction 4 (J4) Part A and Part B Medicare Administrative Contractor (A/B MAC) made, Oct. 5, to two local coverage determinations (LCD).

The revisions were made in response to a recent addition to the list of HCPCS Level II codes payable by Medicare, as noted in the October 2009 quarterly update released Aug. 28 by the Centers for Medicare & Medicaid Services (CMS). (more…)

October 19th, 2009

1 Comment

« Older Entries